Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Azacitidine × Clear all

NCT02260440 2019-09-17

A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer

Phase 2 Completed

31 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms